Healthcare Industry News: abdominal aortic aneurysm
News Release - December 18, 2012
Improved GORE(R) DrySeal Sheath with Hydrophilic Coating Allows for Smooth and Minimally Invasive Endovascular RepairEngineered to Increase Sheath Lubricity and Minimize Coating Particulation for Easier Insertion and Removal in Treatment of Patients with AAA and TAA
FLAGSTAFF, Ariz.--(Healthcare Sales & Marketing Network)--W. L. Gore & Associates (Gore) today introduced GORE® DrySeal Sheath with hydrophilic coating, allowing for easier insertion and removal to and from blood vessels during endovascular repair procedures. The device is designed to increase sheath lubricity with an advantage of minimizing particulation of the hydrophilic coating.
“Hydrophilic coating is an added benefit to a device that is already doing a remarkable job of helping to prevent unnecessary blood loss to the patient, keeping the operating field free from excess blood and allowing the physician to maintain focus on the endovascular procedure at hand,” said Alan Lumsden, MD, Medical Director, Methodist DeBakey Heart and Vascular Center in Houston. Lumsden performed the very first procedure using GORE DrySeal Sheath in May 2010. “This key improvement to the GORE DrySeal Sheath offers clear advantages to both the physician and the patient.”
The GORE DrySeal Sheath is comprised of the innovative hemostatic GORE DrySeal Sheath valve attached to the introducer sheath. The GORE DrySeal Sheath valve is truly unique in that it is pressurized to create a seal, thereby minimizing blood loss and accommodating multiple wires and catheters simultaneously. The valve consists of a silicone outer tube and an inner film tube that create an effective hemostatic seal that easily adapts to the profiles of the inserted devices.
Gore Aortic Business Leader Ryan Takeuchi added, “Endovascular repair of abdominal aortic aneurysms and thoracic aortic aneurysms is proven to be a successful alternative to open surgical repair and we work with physicians continuing to seek improvements to the procedure. Gore’s commitment to innovation and improved patient outcomes drives product enhancements such as this.”
Gore originally received FDA clearance for GORE DrySeal Sheath in April 2010. The device is used in conjunction with the GORE® EXCLUDER® AAA Endoprosthesis to aid in the minimally invasive treatment of patients with abdominal aortic aneurysms (AAA). It is also used with the Conformable GORE® TAG® Thoracic Endoprosthesis in patients with isolated lesions of the Descending Thoracic Aorta (DTA).
ABOUT W. L. GORE & ASSOCIATES
The Gore Medical Products Division has provided creative therapeutic solutions to complex medical problems for more than 35 years. During that time, more than 30 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. The extensive Gore Medical family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia repair, soft tissue reconstruction, staple line reinforcement and sutures for use in vascular, cardiac and general surgery. Gore was recently named one of the best companies to work for by Fortune magazine for the 15th consecutive year. For more information, visit www.goremedical.com.
Products listed may not be available in all markets. GORE®, EXCLUDER®, TAG®, and designs are trademarks of W. L. Gore & Associates.
Source: W. L. Gore
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.